Products mentioned by Haris Panethopoulos
Products Haris Panethopoulos has mentioned or recommended across podcast appearances.
SignalCast may earn a small commission on purchases through these links — at no extra cost to you. As an Amazon Associate we earn from qualifying purchases.
Xarelto
“running phase two trials showing 62–89% bleeding reduction versus Xarelto, publishing in NEJM twice”
Leqvio
by Novartis
“Blackstone invested $2B total—$1B for 50% of Novartis Leqvio royalties plus $750M in credit and two product financings”
abelacimab
“carving abelacimab from Novartis in 2019, running phase two trials showing 62–89% bleeding reduction versus Xarelto”